「Boss Emma Walmsley Hits Jackpot With £13m GSK Payday」の版間の差分
AlvinGirard3226 (トーク | 投稿記録) 細 |
Ariel0364399925 (トーク | 投稿記録) 細 |
||
| 1行目: | 1行目: | ||
| − | Cashing in: GSK boss Emma Walmsley<br><br>GSK boss Emma Walmsley was paid almost £13m last year - taking her total earnings since she took the job to more than £55m.<br><br>The pharmaceuticals giant gave her £12.7m in 2023, including a £1.3m basic salary, over £300,000 of benefits and pension contributions and £11.1m of bonuses.<br><br>That was the biggest pay cheque she has received since taking the job in 2017. In total, Walmsley, | + | Cashing in: [https://loans-online-apply.com/ no credit check payday loans instant approval] GSK boss Emma Walmsley<br><br>GSK boss Emma Walmsley was paid almost £13m last year - taking her total earnings since she took the job to more than £55m.<br><br>The pharmaceuticals giant gave her £12.7m in 2023, including a £1.3m basic salary, over £300,000 of benefits and pension contributions and £11.1m of bonuses.<br><br>That was the biggest pay cheque she has received since taking the job in 2017. In total, Walmsley, 54, has been paid £55.3m since becoming chief executive.<br><br>Her earnings remain well below those of Pascal Soriot, who is chief executive of rival AstraZeneca. <br><br>He was paid £16.9m last year and has received a total of £135m since getting the job in 2012.<br><br>GSK revenues edged up to £30.3billion last year, while profits rose nearly 8pc to £6.1bn. <br><br>Shares are up nearly 15 per cent this year but are broadly unchanged since Walmsley took over.<br><br><br><br><br>RELATED ARTICLES<br><br>Previous<br><br>1<br><br>2<br><br>Next<br><br><br><br>GSK boosted by gonorrhoea drug trial success: Gepotidacin... We're here to stay, declares GSK boss Walmsley: Pharma giant... <br><br>GSK acquires asthma specialist Aiolos Bio in $1.4bn deal<br><br><br><br>Share this article<br><br>Share<br><br><br><br>HOW THIS IS MONEY CAN HELP<br><br>How to choose the best (and cheapest) stocks and shares Isa and the right DIY investing account<br><br><br><br>Pay is again a hot topic in the City with David Schwimmer, boss of the London Stock Exchange Group (LSEG), this week saying UK companies need to offer bosses more to compete with US businesses.<br><br><br><br><br>DIY INVESTING PLATFORMS<br><br><br>Easy investing<br><br><br><br>Stocks & shares Isa<br><br>£1.50 fund dealing<br><br>0.25% fee on fund holdings<br><br>Investment ideas<br><br><br><br>Free fund dealing<br><br>Free fund dealing<br><br>0.45% account fee capped for shares<br><br>Flat-fee investing<br><br><br><br>[https://loans-online-apply.com/ online payday loans no credit check] fees<br><br>From £4.99 a month<br><br>Trade shares and funds for £3.99<br><br>Social investing<br><br><br><br>Social investing<br><br>Share investing<br><br>30+ million global community<br><br>Model portfolios<br><br><br><br>Investment account<br><br>Free fund dealing<br><br>Free financial coaching<br><br><br><br>Affiliate links: If you take out a product This is Money may earn a commission. This does not affect our editorial independence. <br><br><br><br>> Compare the best investing platform for you<br><br>Here's more info regarding [https://loans-online-apply.com/ loans online instant approval] take a look at our web-page. |
2024年5月4日 (土) 12:15時点における最新版
Cashing in: no credit check payday loans instant approval GSK boss Emma Walmsley
GSK boss Emma Walmsley was paid almost £13m last year - taking her total earnings since she took the job to more than £55m.
The pharmaceuticals giant gave her £12.7m in 2023, including a £1.3m basic salary, over £300,000 of benefits and pension contributions and £11.1m of bonuses.
That was the biggest pay cheque she has received since taking the job in 2017. In total, Walmsley, 54, has been paid £55.3m since becoming chief executive.
Her earnings remain well below those of Pascal Soriot, who is chief executive of rival AstraZeneca.
He was paid £16.9m last year and has received a total of £135m since getting the job in 2012.
GSK revenues edged up to £30.3billion last year, while profits rose nearly 8pc to £6.1bn.
Shares are up nearly 15 per cent this year but are broadly unchanged since Walmsley took over.
RELATED ARTICLES
Previous
1
2
Next
GSK boosted by gonorrhoea drug trial success: Gepotidacin... We're here to stay, declares GSK boss Walmsley: Pharma giant...
GSK acquires asthma specialist Aiolos Bio in $1.4bn deal
Share this article
Share
HOW THIS IS MONEY CAN HELP
How to choose the best (and cheapest) stocks and shares Isa and the right DIY investing account
Pay is again a hot topic in the City with David Schwimmer, boss of the London Stock Exchange Group (LSEG), this week saying UK companies need to offer bosses more to compete with US businesses.
DIY INVESTING PLATFORMS
Easy investing
Stocks & shares Isa
£1.50 fund dealing
0.25% fee on fund holdings
Investment ideas
Free fund dealing
Free fund dealing
0.45% account fee capped for shares
Flat-fee investing
online payday loans no credit check fees
From £4.99 a month
Trade shares and funds for £3.99
Social investing
Social investing
Share investing
30+ million global community
Model portfolios
Investment account
Free fund dealing
Free financial coaching
Affiliate links: If you take out a product This is Money may earn a commission. This does not affect our editorial independence.
> Compare the best investing platform for you
Here's more info regarding loans online instant approval take a look at our web-page.
